MassMutual Private Wealth & Trust’s Ascendis Pharma A/S ASND Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.07K	Buy	+4	New	+$934	﹤0.01%	2157

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

MassMutual Private Wealth & Trust's ASND Position: Q2 2026 in Review

MassMutual Private Wealth & Trust opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 4 shares worth $1.07K. The stake represents ﹤0.01% of the portfolio and ranks #2157 among its holdings.

313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

MassMutual Private Wealth & Trust held 4 shares of Ascendis Pharma A/S worth $1.07K as of Q2 2026.
Ascendis Pharma A/S was a new MassMutual Private Wealth & Trust position in Q2 2026.
Ascendis Pharma A/S made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2157 holding.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.